LEADER 02585nam  2200541Ia 450 
001 9910822487603321
005 20230801230457.0
010   $a90-6299-859-3
035   $a(CKB)2670000000343084
035   $a(EBL)1153134
035   $a(OCoLC)831118671
035   $a(SSID)ssj0000921070
035   $a(PQKBManifestationID)11484062
035   $a(PQKBTitleCode)TC0000921070
035   $a(PQKBWorkID)10940492
035   $a(PQKB)10453115
035   $a(MiAaPQ)EBC1153134
035   $a(Au-PeEL)EBL1153134
035   $a(CaPaEBR)ebr10674877
035   $a(EXLCZ)992670000000343084
100   $a20130408d2012      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aVascular considerations in glaucoma$b[electronic resource] $ecurrent perspectives /$fedited by Alon Harris
210   $aAmsterdam, Netherlands $cKugler$d2012
215   $a1 online resource (126 p.)
300   $aDescription based upon print version of record.
311   $a90-6299-235-8 
320   $aIncludes bibliographical references.
327   $aABOUT THE AUTHORS; 1. BACKGROUND - THE EMERGENCE OF THEVASCULAR DYSREGULATION THEORY; 2. CLINICAL MEASUREMENT OF OCULAR BLOODFLOW; 3. AUTOREGULATION; 4. VASCULAR RISK FACTORS; 5. DIURNAL VARIATIONS OF INTRAOCULARPRESSURE, BLOOD PRESSURE AND PERFUSIONPRESSURE; 6 THE RELATIONSHIP BETWEEN BLOOD FLOWAND STRUCTURE; 7. OCULAR BLOOD FLOW AND VISUAL FUNCTION; 8. CEREBROSPINAL FLUID PRESSURE ANDGLAUCOMA; 9. TOPICAL MEDICATIONS AND OCULAR BLOODFLOW
330   $aPrefaceOpen angle glaucoma (OAG) is one of the leading causes of impaired vision worldwide. The pathogenesis of glaucomatous optic neuropathy remains poorly understood, and several pathogenic mechanisms are proposed to coexist. As the world population ages, OAG will become more prevalent and advances in the diagnosis and treatment of glaucomatous optic neuropathy are important to protect and improve the quality of life of our aging population.Treatment of OAG has been directed at lowering intraocular pressure (IOP) which is the only current therapeutic strategy available to patients with glauc
606   $aGlaucoma
606   $aRetina$xBlood-vessels
615  0$aGlaucoma.
615  0$aRetina$xBlood-vessels.
676   $a617.7
676   $a617.74100223
701   $aHarris$b Alon$01643019
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910822487603321
996   $aVascular considerations in glaucoma$94040676
997   $aUNINA